Skip to content
Screener

Other geography segments

US
$166.64M
IT
$5.14M
FR
$3M
GB
$2.94M
DE
$2.17M

Similar metrics at other companies

PTC Therapeutics logo
PTCTBR — Revenue
$41.21M+334%
Innovex International logo
INVXBR — Revenue
$9.93M+110%
Stepan logo
SCLBR — Revenue
$39.06M+15.4%
Transocean logo
RIGBR — Revenue
$167M-24.4%
Helix Energy Solutions Group logo
HLXBR — Revenue
$88.63M+91.1%
Dana Incorporated logo
DANBR — Revenue
$107M-10.1%

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$418.73M-18.1%
Enterprise value$552.6M-11.4%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(Unaudited, U.S. Dollars, in thousands, except per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net sales$210,933$203,121$407,641$396,767
Cost of sales61,22663,588118,388135,615
Gross profit149,707139,533289,253261,152
Sales, general, and administrative138,030136,493272,941269,474
Research and development15,94415,93431,26435,700
Acquisition-related amortization, impairment, and remeasurement (Note 11)3,8673,1097,61820,854
Operating loss(8,134)(16,003)(22,570)(64,876)
Interest expense, net(6,085)(3,950)(11,749)(8,456)

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s BR — revenue?
Orthofix Medical Inc. (OFIX) reported BR — revenue of $1.92M in Q2 2026.
How has Orthofix Medical Inc.'s BR — revenue changed year-over-year?
Orthofix Medical Inc.'s BR — revenue increased by 94.1% year-over-year, from $988K to $1.92M.
What is the long-term trend for Orthofix Medical Inc.'s BR — revenue?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s BR — revenue has grown at a -1.4% compound annual growth rate (CAGR), from $5.11M to $4.84M.
What does BR — revenue mean?
This metric represents the total net sales generated from contracts with customers within a specific geographic or operational segment, excluding any assessed taxes such as sales or value-added taxes. It serves as a primary indicator of the market demand and commercial performance for the company's products or services in that specific region. Tracking this revenue stream helps investors assess the segment's contribution to overall top-line growth and its relative importance within the company's broader portfolio.

Ask your AI about Orthofix Medical Inc.'s br — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude